Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001178913-24-003870
Filing Date
2024-11-29
Accepted
2024-11-29 06:06:53
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 zk2432410.htm 424B3 66353
2 image0.jpg GRAPHIC 394107
3 image00001.jpg GRAPHIC 4852
  Complete submission text file 0001178913-24-003870.txt   617091
Mailing Address 12 ABBA HILLEL ROAD RAMAT GAN L3 5250606
Business Address 12 ABBA HILLEL ROAD RAMAT GAN L3 5250606 972-8-6286005
Silexion Therapeutics Corp (Filer) CIK: 0002022416 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-282017 | Film No.: 241513062
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)